Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I CARE: Vitamin E for Cardiovascular Prevention in Hp 2-2 Diabetic Patients
NCT00220831Phase 3Terminated
- Sponsor
- Technion-Israel Institute of Technology
- Start
- Apr 2005
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vitamin e in cardiovascular disease (CVD), myocardial infarction (MI) and stroke, sponsored by Technion-Israel Institute of Technology. Primary endpoint: Composite of CVD mortality, non-fatal MI, and stroke at 4.5 years. Started Apr 2005; status: terminated.
02
Drugs
vitamin e
03
Conditions
cardiovascular disease (CVD)myocardial infarction (MI)stroke
Beyond the preview
Go deeper on NCT00220831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220831.